Ovid Therapeutics Inc. · NASDAQ:OVID

Balyasny Asset Management L.P. reported a 5.33% stake in Ovid Therapeutics Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed May 15, 2026

Balyasny Asset Management L.P. reported a 5.33% stake in Ovid Therapeutics Inc., 7,029,223 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).

Stake
5.33%
Shares
7,029,223
Intent
Passive
What changed
Crossed above 5%
Filed together
5 holders

The filing in full

HolderStakeShares
Balyasny Asset Management L.P.5.33%7,029,223
BAM GP LLC5.33%7,029,223
Balyasny Asset Management Holdings LP5.33%7,029,223
Dames GP LLC5.33%7,029,223
Dmitry Balyasny5.33%7,029,223

Source

View original at SEC

Related